MDT
Medtronic Plc
NYSE · Healthcare · Medical - Devices · IE
$92.13
−0.69%Jul 31, 2026, 08:30 UTC
CoreMap raised $37 million in an oversubscribed Series C financing round, with participation from Medtronic.
Source:Jul 31, 2026, 04:30 UTC
Aer Lingus announced it will end flights to Minneapolis-Saint Paul International Airport in October 2026, after serving the route since 2019.
Source:Jul 21, 2026, 11:00 UTC
Medtronic unveiled Touch Surgery Aide, an AI-native surgical computing platform, at the Society of Robotic Surgery 2026 conference.
Jul 20, 2026, 21:45 UTC
A lawsuit was filed in Florida federal court by plaintiff Christine Hunter against Medtronic, alleging that a defective Medtronic MiniMed insulin pump caused her to fall into a diabetic coma.
Source:Jul 17, 2026, 10:56 UTC
Olympus announced the appointment of Brian Barry, currently at Medtronic, as Chief Quality and Regulatory Officer (CQO) effective August 1, to address FDA warnings over quality management issues.
Source:Jul 16, 2026, 13:00 UTC
Medtronic completed its acquisition of SPR Therapeutics, Inc.
Source:Jul 3, 2026, 10:00 UTC
Medical technology giant Medtronic suffered a data breach in April 2026, when the extortion group ShinyHunters accessed its corporate IT systems, compromising the personal and medical information of over 3.8 million individuals.
Jul 1, 2026, 00:00 UTC
Omnicell, Inc. appointed Nnamdi Njoku as President and Chief Operating Officer, effective June 2026.
Source:Jun 12, 2026, 15:00 UTC
Medtronic completed its acquisition of Scientia Vascular for $550 million.
Source:Jun 9, 2026, 17:41 UTC
Medtronic plc announced its intention to acquire SPR Therapeutics, Inc. for approximately $650 million in cash.
Source:Jun 8, 2026, 16:05 UTC
Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
Jun 8, 2026, 11:41 UTC
The U.S. Food and Drug Administration approved Medtronic's Hugo robotic-assisted surgery platform for urologic procedures in December 2025.
Source:Jun 5, 2026, 13:39 UTC
Medtronic launched its Stealth AXiS robotic system for spine, cranial, and ENT surgeries in April 2025, with rollout in Kentucky, Virginia, West Virginia, and California.
Source:Jun 5, 2026, 01:56 UTC
Medtronic reported fiscal fourth-quarter adjusted earnings of $1.55 per share and revenue of $9.8 billion, exceeding analyst expectations.
Jun 4, 2026, 10:34 UTC
CereVasc, Inc. completed an $85 million Series C financing led by Piper Sandler Merchant Banking with participation from Johnson & Johnson Innovation – JJDC, Inc., Medtronic, and existing investors.
Source:Jun 3, 2026, 11:05 UTC
Medtronic submitted 510(k) filings to expand the Hugo robotic-assisted surgery system into general and gynecologic specialties in the United States.
Source:Jun 3, 2026, 00:00 UTC
Medtronic plc reported Q4 fiscal 2026 financial results with revenue of $9.807 billion and GAAP diluted EPS of $0.96.
← PreviousPage 2